Treatment of collagen‐induced arthritis by Natura‐α via regulation of Th‐1/Th‐17 responses |
| |
Authors: | Simon Glatigny Marie‐Agnès Blaton Simon K Mencher Sylvie Mistou Bruno Lucas Catherine Fournier Long G Wang Gilles Chiocchia |
| |
Institution: | 1. Institut Cochin, Université Paris Descartes CNRS (UMR 8104), Paris, France;2. INSERM U567, Département d'Immunologie, Paris, France;3. Natrogen Therapeutics International Inc., NY, USA;4. H?pital Ambroise Paré, Boulogne‐Billancourt, France |
| |
Abstract: | Cytokines and CD4+ Th cells play a crucial role in the pathogenesis of rheumatoid arthritis. Among the Th populations, Th‐1 and Th‐17 have been described as pathogenic in collagen‐induced arthritis (CIA) whereas Th‐2 and Treg were found to have protective effects. The objective of this study was to examine the affect of Natura‐α, a newly developed cytokine regulator, on CIA and on Th cell development. Natura‐α treatment was administered before or during arthritis induction. Anti‐type II collagen antibodies and cytokine expression were evaluated by ELISA. Emergence of CD4+CD25+Foxp3+ T cells was assessed by flow cytometry. Th‐17 differentiation of naive CD4 T cells was assessed in cultures with anti‐CD3 and anti‐CD28. We showed that Natura‐α both prevented and treated CIA. We further demonstrated that in vivo treatment with Natura‐α inhibited IL‐17 production and anti‐type II collagen IgG development. We showed in vitro, using an APC‐free system, that Natura‐α acted directly on differentiating T cells and inhibiting the formation of Th‐1 and Th‐17 cells but did not affect Th‐2 cells. Since Natura‐α inhibits a large spectrum of important pathogenic factors in CIA, it may provide a new and powerful approach to the treatment of rheumatoid arthritis and other inflammatory diseases. |
| |
Keywords: | Arthritis Cytokine Th‐1 Th‐17 |
|
|